RAF inhibitor compounds and methods
US7491829B2 · kind B2 · utility
8Cited by
15References
49Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 2, 2006 |
| Grant date | Feb 17, 2009 |
| Priority date | — |
| Expiry date | Feb 2, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pyrazolyl compounds of Formulas Ia and Ib are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using pyrazolyl compounds for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.